HSPB8 is highly expressed in BC tumors, particularly in the ER-positive tumors [26, 27], and in cell lines of hormone-resistant BC, suggesting its involvement in the acquisition of resistance to hormone therapy [28]. This evidence concerns the gene HSPB8 and breast cancer.